via Hello Tomorrow
RxAll is a nanoscanner for ensuring drug quality in real time.
After this 1 min-pitch, Adebayo Alonge, Co-Founder and CEO of RxAll, was crowned Grand Winner of the Hello Tomorrow Global Challenge and won the €100,000 prize funded by BNP Paribas.
Hello Tomorrow is a global organisation dedicated to leveraging deep technologies to help solve world challenges. Through our Global startup Challenge, which has had 18,000 applications from over 100 countries since 2014, we identify deeptech solutions by partnering with universities and research labs.
No comments:
Post a Comment